Sertraline Hydrochloride Tablet, Film Coated
Product Images NDC 70518-2812

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 70518-2812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Sertraline HCI is a medication that comes in the form of a tablet with a strength of 50 mg. The NDC number is 70518-2812-00 and it is manufactured by Aurobindo Pharma in Hyderabad, India. The package contains 30 tablets and the expiration date and lot number information is not available. The medication should be stored at room temperature between 25-30°C (59-86°F) and kept out of reach of children. The directions for use can be found in the package insert. This medication is available only by prescription and has been repackaged by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Mm2 (Sertraline HCl 50mg 70518 2812 01)

Mm2 (Sertraline HCl 50mg 70518 2812 01)
Sertraline HCI is a prescription medication manufactured by Aurobindo Pharma in Hyderabad, India. It comes in a tablet form with a strength of 50 mg and is sold in a bottle containing 90 tablets. The National Drug Code (NDC) for this medication is 70518-2812-01. The medication should be stored at temperatures between 25-30°C (77°F) with allowed excursions between 15-30°C (59-86°F) and kept out of reach of children. It comes with directions for use which should be followed as per the package insert. The medication has been repackaged by RemedyRepack Inc., Indiana, PA 15701, and is available only through a prescription.*
FDA Label Image

Sertraline HCl 50mg 70518 2812 02

Sertraline HCl 50mg 70518 2812 02
Sertraline HCI is a medication used for treating depression, obsessive-compulsive disorder, and panic disorders. The given information includes the NDC number, lot number, and expiry date of the medicine. The package contains 30 tablets of 50 mg manufactured by Aurobindo Pharma in Hyderabad, India. It must be kept away from children at a temperature between 15-30°C (59-86°F) and stored in a dry area. The directions for use are provided in the package insert. The medication is available only through prescription and is repackaged by RemedyRepack Inc. in Indiana.*
FDA Label Image

Sertraline HCl 50mg 70518 2812 03

Sertraline HCl 50mg 70518 2812 03
Sertraline HCI is a prescription medication manufactured by Aurobindo Pharma in Hyderabad, India. The bottle contains 28 tablets of 50mg each, and its NDC number is 70518-2812-03. The expiration date and lot number are not available. The medication should be stored at room temperature, between 15-30°C, and out of the reach of children. Patients should consult with their health care provider and read the package insert before using. This medication is Rx only, and it has been repackaged by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Sertraline HCl 50mg 70518 2812 04

Sertraline HCl 50mg 70518 2812 04
Sertraline HCI is a medication with NDC number: 70518-2812-04. It is a 50mg tablet manufactured by Aurobindo Pharma in Hyderabad, India. The medication comes in a bottle of 30 tablets and should be stored in a cool place away from the reach of children. The package insert should be consulted for guidance on usage. The medication was repackaged by RemedyRepack Inc. in Indiana. The lot number and expiry date are not available from the provided text.*
FDA Label Image

Chemical Structure (Sertraline Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.